drugset / Trial / NCT00659659
A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma
RandomizedSingle-groupDouble-blindTreatment
Summary
Evaluate the safety and tolerability of MEDI-563 in adults with asthma and the effects of MEDI-563 on eosinophil counts in airway mucosal biopsies
Timeline
- Start
- 2008-01
- Primary completion
- 2011-01
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Benralizumab | Monoclonal antibody | 1 mg/kg | Intravenous |
| Subject | Benralizumab | Monoclonal antibody | 100 mg | Intravenous |
| Subject | Benralizumab | Monoclonal antibody | 200 mg | Intravenous |